OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
EBV is a B cell tropic, oncogenic gamma-herpes virus that infects more than 90% of the adult population worldwide. In immunosuppressed individuals, EBV may cause a wide spectrum of pathologies, ranging from lymphoproliferation to frank lymphoma.
EBV-driven B cell expansion is a metabolically demanding process. Targeting metabolic vulnerabilities of B cells en route to virus-driven transformation may thus offer therapeutic opportunities.
In my seminar, I will present emerging data on EBV-driven metabolic changes required for latent infection of B cells. Molecular metabolic aspects, preclinical models and clinical data will be discussed.
